CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

OCT China: Education key to unlocking DCT adoption in China

ConferenceNeutral
AI Analysis

Summary

At OCT China 2026, compliance and cost concerns were identified as the main barriers to decentralized clinical trial (DCT) adoption in China, with education highlighted as a key solution.

Importance:2/10
Sentiment:
0.00
DCT adoptionChinacompliancecost concernseducation

Read the original article

Published by Clinical Trials Arena on September 23, 2026 8:54 AM

Read Original